Stellus Capital Investment Corp. (SCM) - Q1 2020 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2020. Stellus Capital Investment Corp. is an externally managed, closed-end, non-diversified business development company (BDC) regulated under the Investment Company Act of 1940. The company invests primarily in private U.S. middle-market companies through debt and equity instruments. The reporting period coincided with the onset of the global COVID-19 pandemic, which significantly impacted market valuations and economic activity.
Key Financial Metrics
| Metric | Q1 2020 | Q1 2019 |
|---|---|---|
| Net Asset Value (NAV) per Share | $11.55 | $14.14 |
| Total Assets | $649.1 million | $648.5 million |
| Total Liabilities | $424.1 million | $377.9 million |
| Net Assets | $224.9 million | $270.6 million |
| Investment Income | $15.3 million | $13.8 million |
| Net Investment Income | $6.2 million | $4.3 million |
| Net Realized Gain | $1.3 million | $10.2 million |
| Net Unrealized Depreciation | ($51.5 million) | ($4.4 million) |
| Net (Decrease) Increase in Net Assets from Operations | ($43.9 million) | $10.1 million |
| Cash and Cash Equivalents | $35.0 million | $16.1 million |
| Asset Coverage Ratio | 1.87x | 3.14x |
Material Changes vs. Prior Period
- Portfolio Valuation: The company recorded a net unrealized depreciation of $51.5 million, compared to $4.4 million in Q1 2019. Management attributes this primarily to the negative economic impact and increased uncertainty caused by the COVID-19 pandemic, alongside approximately $17.2 million in portfolio company-specific depreciation.
- Net Assets: Net assets decreased by approximately $45.7 million (16.9%) from the prior year-end, driven largely by the unrealized losses.
- Leverage: Borrowings under the Credit Facility increased significantly, with the outstanding balance rising from $160.5 million at year-end 2019 to $209.1 million at March 31, 2020. Total debt obligations (Credit Facility, SBA Debentures, and Notes) increased to approximately $415 million.
- Non-Accrual Status: The number of loans on non-accrual status increased from 2 at December 31, 2019, to 4 at March 31, 2020. These loans represented 5.6% of the loan portfolio at cost.
Guidance, Outlook, and Risks
- COVID-19 Impact: The filing highlights significant uncertainty regarding the duration and spread of the virus. Management notes that while all borrowers on accrual paid principal and interest due during the quarter, there has been an increase in funding requests for revolving and delayed draw term loans. The company funded $11.7 million in such requests during March.
- Dividend Policy Change: Subsequent to the period end (April 20, 2020), the Board announced a change in the dividend payment schedule from monthly to quarterly, effective with the quarter ended June 30, 2020, to better match income timing.
- Liquidity: The company maintains sufficient liquidity to fund unfunded commitments ($34.7 million as of March 31, 2020) and meet covenant requirements. The Credit Facility commitment expires October 10, 2020, and the company is in the process of amending it to extend the revolving period.
- Board Changes: Subsequent to the period end, two directors (Paul Keglevic and Joshua T. Davis) announced their retirement/resignation effective May 15, 2020, reducing the Board size from 7 to 5 members.
Investor Verification Checklist
- Portfolio Quality: Verify the specific portfolio companies placed on non-accrual status and the magnitude of the $17.2 million in company-specific depreciation mentioned in the notes.
- Credit Facility Extension: Confirm the successful amendment and extension of the Credit Facility, which was in negotiation as of May 8, 2020.
- Dividend Sustainability: Monitor the new quarterly dividend schedule and the company's ability to maintain distributions given the shift in income timing and potential future unrealized losses.
- Unfunded Commitments: Track the reduction in unfunded commitments (which dropped to $22.7 million by May 8, 2020) and the company's ability to fund remaining obligations without further dilution or leverage increases.
- NAV vs. Market Price: Note the significant discount of the market price ($7.29) to the NAV ($11.55) as of period end, which may impact future equity raising capabilities.